Goel Amit, Shivaprasad Channabasappa, Kolly Anish, Sarathi H A Vijaya, Atluri Sridevi
Department of Endocrinology, Vydehi Institute of Medical Sciences and Research Centre, Bangalore, Karnataka, India.
PLoS One. 2017 Sep 7;12(9):e0183973. doi: 10.1371/journal.pone.0183973. eCollection 2017.
The early diagnosis of diabetic peripheral neuropathy (DPN) is challenging. Sudomotor dysfunction is one of the earliest detectable abnormalities in DPN. The present study aimed to determine the diagnostic performance of the electrochemical skin conductance (ESC) test in detecting early DPN, compared with the vibration perception threshold (VPT) test and diabetic neuropathy symptom (DNS) score, using the modified neuropathy disability score (NDS) as the reference standard. Five hundred and twenty-three patients with type 2 diabetes underwent an NDS-based clinical assessment for neuropathy. Participants were classified into the DPN and non-DPN groups based on the NDS (≥ 6). Both groups were evaluated further using the DNS, and VPT and ESC testing. A receiver-operator characteristic (ROC) curve analysis was performed to compare the efficacy of ESC measurements with those of DNS and VPT testing in detecting DPN. The DPN group (n = 110, 21%) had significantly higher HbA1c levels and longer diabetes durations compared with the non-DPN group (n = 413). The sensitivity of feet ESC < 60 μS, VPT testing, and DNS in detecting DPN were 85%, 72%, and 52%, respectively. The specificity of feet ESC, VPT, and DNS in detecting DPN were 85%, 90% and 60% respectively. The areas under the curves of the ROC plots for feet ESC, VPT testing, and DNS were 0.88, 0.84, and 0.6, respectively. A significant inverse linear relationship was noted between VPT and feet ESC (r = -0.45, p = <0.0001). The odds ratios for having DPN, based on the mean feet ESC testing < 60 μS, VPT testing > 15 V, and DNS ≥ 1, were 16.4, 10.9 and 1.8, respectively. ESC measurement is an objective and sensitive technique for the early detection of DPN. Feet ESC measurement was superior to VPT testing for identifying patients with early DPN.
糖尿病周围神经病变(DPN)的早期诊断具有挑战性。汗腺功能障碍是DPN最早可检测到的异常之一。本研究旨在以改良的神经病变残疾评分(NDS)作为参考标准,比较电化学皮肤电导(ESC)测试与振动觉阈值(VPT)测试及糖尿病神经病变症状(DNS)评分在检测早期DPN方面的诊断性能。523例2型糖尿病患者接受了基于NDS的神经病变临床评估。根据NDS(≥6)将参与者分为DPN组和非DPN组。两组均进一步采用DNS、VPT和ESC测试进行评估。进行受试者操作特征(ROC)曲线分析,以比较ESC测量与DNS和VPT测试在检测DPN方面的效果。与非DPN组(n = 413)相比,DPN组(n = 110,21%)的糖化血红蛋白水平显著更高,糖尿病病程更长。足部ESC < 60 μS、VPT测试和DNS检测DPN的敏感性分别为85%、72%和52%。足部ESC、VPT和DNS检测DPN的特异性分别为85%、90%和60%。足部ESC、VPT测试和DNS的ROC曲线下面积分别为0.88、0.84和0.6。VPT与足部ESC之间存在显著的负线性关系(r = -0.45,p = <0.0001)。基于平均足部ESC测试< 60 μS、VPT测试> 15 V和DNS≥1,发生DPN的优势比分别为16.4、10.9和1.8。ESC测量是早期检测DPN的一种客观且敏感的技术。足部ESC测量在识别早期DPN患者方面优于VPT测试。